Infection with Plasmodium berghei boosts antibody responses primed by a DNA vaccine encoding gametocyte antigen Pbs48/45

Infection and Immunity

Volumn 74, Issue 4, 2006, Pages 2043-2051

  Haddad, Diana ^a   Maciel, Jorge ^a   Kumar, Nirbhay ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PBS48 45; DNA VACCINE; DNA VACCINE GAMETOCYTE ANTIGEN PBS48 45; MALARIA VACCINE; PARASITE ANTIGEN; PROTOZOAL VACCINE; PROTOZOON ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GAMETOCYTE; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; MALARIA; MOLECULAR CLONING; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELL LINE; CLONE CELLS; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; PLASMODIUM BERGHEI; VACCINES, DNA;

EID: 33645527031     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.74.4.2043-2051.2006     Document Type: Article

References (41)

1. Aguiar, J. C., J. LaBaer, P. L. Blair, V. Y. Shamailova, M. Koundinya, J. A. Russell, F. Huang, W. Mar, R. M. Anthony, A. Witney, S. R. Caruan, L. Brizuela, J. B. Sacci, S. L. Hoffman, and D. J. Carucci. 2004. High-throughput generation of P. falciparum functional molecules by recombinational cloning. Genome Res. 14:2076-2082.
2. Ahlborg, N., D. Haddad, A. B. Siddique, C. Roussilhon, C. Rogier, and J. F. Trape. 2002. Antibody responses to the repetitive Plasmodium falciparum antigen Pf332 in humans primed to the parasite. Clin. Exp. Immunol. 129:318-325.
3. Becker, S. I., R. Wang, R. Hedstrom, J. A. Aguiar, T. R. Jones, S. L. Hoffman, and M. J. Gardner. 1998. Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines. Infect. Immun. 66:3457-3461.
4. Beetsma, A. L., T. J. J. M. van de Wiel, R. W. Sauerwein, and W. M. C. Eling. 1998. Plasmodium berghei ANKA: purification of large numbers of infectious gametocytes. Exp. Parasitol. 88:69-72.
5. Carter, R. 2001. Transmission-blocking malaria vaccines. Vaccine 19:2309-2314.
6. Carter, R., P. M. Graves, D. B. Keister, and I. A. Quakyi. 1990. Properties of epitopes of Pfs 48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of Plasmodium falciparum. Parasite Immunol. 12:587-603.
7. Carter, R., N. Kumar, I. Quakyi, M. Good, K. Mendis, P. Graves, and L. Miller. 1988. Immunity to sexual stages of malaria parasites. Prog. Allergy 41:193-214.
8. Coban, C., M. Philipp, J. E. Purcell, D. B. Keister, M. Okulate, D. S. Martin, and N. Kumar. 2004. Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations. Infect. Immun. 72:253-259.
9. Cohen, S., I. A. McGregor, and S. Carrington. 1961. Gamma globulin and acquired immunity to human malaria. Nature 192:733-737.
10. Day, K. P., and K. Marsh. 1991. Naturally acquired immunity to Plasmodium falciparum. Immunol. Today 12:A68-A71.
11. Dearsly, A. L., R. E. Sinden, and I. A. Self. 1990. Sexual development in malarial parasites: gametocyte production, fertility and infectivity to the mosquito vector. Parasitology 100:359-368.
12. Dessens, J. T., A. L. Beetsma, G. Dimopoulos, K. Wengelnick, A. Crisanti, F. C. Kafatos, and R. E. Sinden. 1999. CTRP is essential for mosquito infection by malaria ookinetes. EMBO J. 18:6221-6227.
13. Graves, P. M., A. Doubrosvsky, J. Sattabongkot, and D. Battistutta. 1992. Human antibody responses to epitopes on the Plasmodium falciparum gametocyte antigen Pfs48/45 and their relationship to infectivity of gametocyte carriers. Am. J. Trop. Med. Hyg. 46:711-719.
14. Haddad, D., E. Bilcikova, A. A. Witney, J. M. Carlton, C. E. White, P. L. Blair, R. Chattopadhyay, J. Russel, E. Abot, Y. Charoenvit, J. Aguiar, D. J. Carucci, and W. R. Weiss. 2004. Novel antigen identification method for discovery of protective malaria antigens by rapid testing of DNA vaccines encoding exons from the parasite genome. Infect. Immun. 72:1594-1602.
15. Hay, S. I., C. A. Guerra, A. J. Tatem, A. M. Noor, and R. W. Snow. 2004. The global distribution and population at risk of malaria: past, present and future. Lancet Infect. Dis. 4:327-336.
16. Hoffman, S. L. (ed.). 1996. Malaria vaccine development: a multi-immune approach, p. 1-13. ASM Press, Washington, D.C.
17. Janse, C. J., E. G. Boorsma, J. Ramesar, P. H. van Vianen, R. van der Meer, P. Zenobi, O. Casaglia, B. Mons, and F. M. van der Berg. 1989. Plasmodium berghei: gametocyte production, DNA content, and chromosome-size polymorphisms during asexual multiplication in vivo. Exp. Parasitol. 68:272-284.
18. Janse, C. J., J. Ramesar, F. M. van den Berg, and B. Mons. 1992. Plasmodium berghei: in vivo generation and selection of karyotype mutants and non-gametocyte producer mutants. Exp. Parasitol. 74:1-10.
19. Kaslow, D. 1997. Transmission-blocking vaccines: uses and current development. Int. J. Parasitol. 2:183-189.
20. Kaushal, D. C., R. Carter, J. Rener, C. A. Grotendorst, L. H. Miller, and R. J. Howard. 1983. Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes. J. Immunol. 131:2557-2562.
21. Kocken, C. H., J. Jansen, A. M. Kaan, P. J. Beckers, T. Ponnudurai, D. C. Kaslow, R. N. Konings, and J. G. Schoenmakers. 1993. Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum. Mol. Biochem. Parasitol. 61:59-68.
22. Kumar, N., and R. Carter. 1984. Biosynthesis of the target antigens of antibodies blocking transmission of Plasmodium falciparum. Mol. Biochem. Parasitol. 13:333-342.
23. Lobo, C. A., R. Dhar, and N. Kumar. 1999. Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies. Infect. Immun. 67:1688-1693.
24. Long, T. T. A., S. Nakazawa, M. C. Huaman, and H. Kanbara. 2002. Influence of anti-malarial treatment on acquisition of immunity in Plasmodium berghei NK65 malaria. Clin. Diagn. Lab. Immunol. 9:933-934.
25. Marsh, K., L. Otoo, R. J. Hayes, D. C. Carson, and B. M. Greenwood. 1989. Antibodies to blood-stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans. R. Soc. Trop. Med. Hyg. 3:293-303.
26. McGregor, I. A., H. M. Gilles, and H. J. Walters. 1956. Effects of heavy and repeated malarial infections on Gambian infants and children. Effects of erythrocytic parasitization. Br. Med. J. 2:686-692.
27. Mendis, K. N., Y. D. Munesinghe, Y. N. Y. De Silva, I. Keragalla, and R. Carter. 1987. Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans. Infect. Immun. 55:369-372.
28. Paton, M. G., G. C. Barker, H. Matsuoka, J. Ramesar, C. J. Janse, A. P. Waters, and R. E. Sinden. 1993. Structure and expression of a post-transcriptionally regulated malaria gene encoding a surface protein from the sexual stages of Plasmodium berghei. Mol. Biochem. Parasitol. 59:263-275.
29. Ranawaka, M. B., Y. D. Munesinghe, D. M. R. De Silva, R. Carter, and K. N. Mendis. 1988. Boosting of transmission-blocking immunity during natural Plasmodium vivax infections in humans depends upon frequent reinfection. Infect. Immun. 56:1820-1824.
30. Rener, J., P. M. Graves, R. Carter, J. L. Williams, and T. R. Burkot. 1983. Target antigens of transmission-blocking immunity on gametes of Plasmodium falciparum. J. Exp. Med. 158:976-981.
31. Richie, T. L., and A. L. Saul. 2002. Progress and challenges for malaria vaccines. Nat. Insight 415:694-701.
32. Roeffen, W., B. Mulder, K. Teelen, M. Bolmer, W. Eling, G. A. Targett, P. J. Beckers, and R. Sauerwein. 1996. Association between anti-Pfs48/45 reactivity and P. falciparum transmission-blocking activity in sera from Cameroon. Parasite Immunol. 18:103-109.
33. Sinden, R. E., G. A. Butcher, O. Billker, and S. L. Fleck. 1996. Regulation of infectivity of Plasmodium to the mosquito vector. Adv. Parasitol. 38:53-117.
34. Smooker, P. M., A. Rainczuk, N. Kennedy, and T. W. Spithill. 2004. DNA vaccines and their application against parasites-promise, limitations and potential solutions. Biotechnol. Annu. Rev. 10:189-236.
35. Struik, S. S., and E. M. Riley. 2004. Does malaria suffer from lack of memory? Immunol. Rev. 201:268-290.
36. Taylor, R. R., A. Egan, D. McGuinness, A. Jepson, R. Adair, C. Drakely, and E. Riley. 1996. Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting. Int. Immunol. 8:905-915.
37. Thompson, J., C. J. Janse, and A. P. Waters. 2001. Comparative genomics in Plasmodium: a tool for the identification of genes and functional analysis. Mol. Biochem. Parasitol. 118:147-154.
38. van Dijk, M. R., C. J. Janse, J. Thompson, A. P. Waters, J. A. M. Braks, H. J. Dodemont, H. G. Stunnenberg, G. J. van Gemert, R. W. Sauerwein, and W. Eling. 2001. A central role for P48/45 in malaria parasite male gamete fertility. Cell 104:153-164.
39. Vermeulen, A. N., T. Ponnudurai, P. J. Beckers, J. P. Verhave, M. A. Smits, and J. H. Meuwissen. 1985. Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito. J. Exp. Med. 162:1460-1476.
40. Wang, R., T. L. Richie, M. F. Baraceros, N. Rahardjo, T. Gay, J. G. Banania, Y. Charoenvit, J. E. Epstein, T. Luke, D. A. Freilich, J. Norman, and S. L. Hoffman. 2005. Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites. Infect. Immun. 73:2863-2872.
41. World Health Organization. 2005. World health report 2005, p. 5-17.